|
MCTS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1642021508228E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.31579999515819E-08 |
| Normal-vs-Stage2 |
9.81450000000494E-05 |
| Normal-vs-Stage3 |
2.53920000004015E-06 |
| Normal-vs-Stage4 |
1.26529999999736E-06 |
| Stage1-vs-Stage2 |
3.299200E-01 |
| Stage1-vs-Stage3 |
3.753800E-01 |
| Stage1-vs-Stage4 |
2.080500E-02 |
| Stage2-vs-Stage3 |
8.984400E-01 |
| Stage2-vs-Stage4 |
1.856190E-01 |
| Stage3-vs-Stage4 |
1.222820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6840973060539E-11 |
| Normal-vs-AfricanAmerican |
2.761200E-03 |
| Normal-vs-Asian |
6.119700E-02 |
| Caucasian-vs-AfricanAmerican |
7.982100E-02 |
| Caucasian-vs-Asian |
6.076600E-01 |
| AfricanAmerican-vs-Asian |
9.749800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75670034074926E-10 |
| Normal-vs-Female |
1.06240000130597E-08 |
| Male-vs-Female |
3.295400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.340860E-03 |
| Normal-vs-Age(41-60Yrs) |
8.92679996589152E-09 |
| Normal-vs-Age(61-80Yrs) |
1.4120999924927E-09 |
| Normal-vs-Age(81-100Yrs) |
1.640070E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.774000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.481000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.800600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.555000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.626000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.319400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.179400E-03 |
| Normal-vs-Grade 2 |
8.94749996316335E-09 |
| Normal-vs-Grade 3 |
8.34800000237834E-08 |
| Normal-vs-Grade 4 |
1.51208999999985E-05 |
| Grade 1-vs-Grade 2 |
3.549000E-01 |
| Grade 1-vs-Grade 3 |
7.302400E-01 |
| Grade 1-vs-Grade 4 |
5.403800E-02 |
| Grade 2-vs-Grade 3 |
3.165400E-01 |
| Grade 2-vs-Grade 4 |
1.308640E-01 |
| Grade 3-vs-Grade 4 |
4.017900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.93220000005634E-07 |
| Normal-vs-ccB subtype |
2.86810000194038E-08 |
| ccA subtype-vs-ccB subtype |
1.884380E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.08459999157174E-09 |
| Normal-vs-N1 |
1.010480E-04 |
| N0-vs-N1 |
8.018400E-01 |
|
|
